https://www.selleckchem.com/products/gossypol.html
Major complications within 30 days occurred more frequently in AVNA patients than non-AVNA patients (7.3% vs. 2.0%, p .001). The risk of major complications through 36-months was higher in AVNA patients (hazard ratio 3.81, 95% confidence interval 2.33-6.23, p .001). Intermittent loss of capture occurred in three AVNA patients (1.6%), all were within 30 days of implant and required system revision. There were no device macrodislodgements or unexpected device malfunctions. Concomitant AVN ablation and leadless pacemaker implant
Gefällt mir
Kommentar
Teilen
